Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GLFD

Guilford (GLFD)

Guilford Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GLFD
DateTimeSourceHeadlineSymbolCompany
30/09/200508:27PR Newswire (US)Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA MergerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/09/200521:00Business WireMGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting PeriodNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/08/200500:11PR Newswire (US)Guilford Pharmaceuticals Reports 2005 Second Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200522:45PR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
03/08/200504:33PR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
25/05/200505:44PR Newswire (US)Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
19/05/200505:00PR Newswire (US)Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCONASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/05/200505:39PR Newswire (US)Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant GliomaNASDAQ:GLFDGuilford Pharmaceuticals (MM)
12/05/200501:01PR Newswire (US)AGGRASTAT(R) Injection Strategy Trial Data Published in JAMANASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200523:42PR Newswire (US)Guilford Pharmaceuticals Reports 2005 First Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200522:45PR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/05/200523:00PR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/04/200504:07PR Newswire (US)Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development ProgramNASDAQ:GLFDGuilford Pharmaceuticals (MM)
06/04/200522:45PR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
06/04/200503:31PR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
25/03/200504:04PR Newswire (US)Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary EndpointNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/03/200503:03PR Newswire (US)Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/03/200507:55PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Year-End Financial ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200523:45PR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/02/200503:42PR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/12/200409:30PR Newswire (US)Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net ProceedsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
03/12/200400:45PR Newswire (US)Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) ProNASDAQ:GLFDGuilford Pharmaceuticals (MM)
23/11/200401:03PR Newswire (US)Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/11/200409:30PR Newswire (US)Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ RulesNASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/11/200400:01PR Newswire (US)Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford PharmaceuticalsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
13/11/200402:58PR Newswire (US)AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/11/200404:11PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Third Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
06/11/200400:30PR Newswire (US)Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004NASDAQ:GLFDGuilford Pharmaceuticals (MM)
28/09/200400:33PR Newswire (US)Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends UntilNASDAQ:GLFDGuilford Pharmaceuticals (MM)
23/09/200400:03PR Newswire (US)Guilford to Present at UBS Global Life Sciences ConferenceNASDAQ:GLFDGuilford Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:GLFD